medroxyprogesterone acetate (MPA)
Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor Salirasib
13
Conservative Medroxyprogesterone Acetate Therapy in Early Stage of Endometrial Carcinoma Associated with Phosphatase and Tensin Homolog Expression
13
The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells
15
Development of Immunochemical Methods for Purification and Detection of the Steroid Drug Medroxyprogesterone Acetate
16
Formulation development and evaluation of medroxyprogesterone acetate injectable suspension
6
Counting the costs: Comparing depot medroxyprogesterone acetate and norethisterone oenanthate utilisation patterns in South Africa
9
Endocrine and Ovarian Changes in Response to the Ram Effect in Medroxyprogesterone Acetate-primed Corriedale Ewes During the Breeding and Nonbreeding Season
12
Review of Contraception with Depot Medroxyprogesterone Acetate at the University of Port Harcourt Teaching Hospital, Port Harcourt, Southern Nigeria
6
Trace Elements Levels and Blood Pressure in Ghanaian Women Using Depot Medroxyprogesterone Acetate Contraceptive
7
High-risk sexual behaviors while on depot medroxyprogesterone acetate as compared to oral contraception
6
Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery
8
A Prospective Study of Adolescents Who Choose Among Levonorgestrel Implant (Norplant), Medroxyprogesterone Acetate (Depo-Provera), or the Combined Oral Contraceptive Pill as Contraception
10
Medroxyprogesterone acetate causes the alterations of endoplasmic reticulum related mRNAs and lncRNAs in endometrial cancer cells
11
Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity
18
Comparison of Sexual Dysfunction in Women Using Depo-Medroxyprogesterone Acetate (DMPA) and Cyclofem
7
Scaling up depot medroxyprogesterone acetate (DMPA): a systematic literature review illustrating the AIDED model
12
Association of intimate partner vasectomy, use of long acting progestogen based contraceptives and intra uterine contraceptive devices with risk of ovarian cancer
314
Contraception in HIV-positive female adolescents
11
Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits
11
Progesterone- primed ovarian stimulation in polycystic ovarian syndrome: An RCT
6